| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $60.6M | — | -48.0% |
| Cost of Revenue | $41.5M | — | -43.6% |
| Gross Profit | $19.2M | — | -55.5% |
| R&D Expense | $8.8M | — | +6.8% |
| SG&A Expense | $12.9M | — | +23.8% |
| Operating Income | -$7.9M | — | -141.9% |
| Interest Expense | $428K | — | +9.7% |
| Net Income | $48.2M | — | -22.0% |
| EPS (Basic) | $0.15 | — | -21.1% |
| EPS (Diluted) | -$0.04 | — | -180.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $126.1M | +20.2% | +38.8% |
| Accounts Receivable | $123.6M | -20.7% | -8.9% |
| Inventory | $95.0M | +6.3% | -26.4% |
| Current Assets | $425.8M | -5.1% | -4.9% |
| Total Assets | $987.5M | -1.8% | +0.5% |
| Current Liabilities | $444.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$22.8M | — | -418.0% |
| Capital Expenditures | $2.9M | — | +21.7% |
| Investing Cash Flow | -$2.8M | — | -20.2% |
| Financing Cash Flow | $29.3M | — | +209.9% |
| Free Cash Flow | -$25.7M | — | -631.8% |
| +30.6% |
| Total Liabilities | $521.4M | -12.4% | -1.4% |
| Stockholders' Equity | $466.1M | +13.5% | +2.6% |